StockData
Upstream Bio, Inc. logo

Upstream Bio, Inc. (UPB) stock

UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.10−0.05 (-2.33%)

Close on Nov 17, 2026Market cap $115.02MP/E –Yield –

Upstream Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Upstream Bio's market cap was $175.27M on Nov 11, 2026, against $1.54B a year earlier. Over the last 2 years it ranged from $32.58M to $1.68B, with a median of $454.95M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$175.27M-88.0%
2025Dec 31, 2025$1.47B+2847.6%
2024Dec 31, 2024$49.74M–

More Upstream Bio figures

See a number that looks wrong?